RNU6-503P

Across TCGA pan-cancer cohorts, RNU6-503P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-503P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-503P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-503P expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

MESO, KIRP, and HNSC are the cancer types where RNU6-503P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
KIRP	OS	Tertile	All	0.550	0.896	<.001	108	view →
HNSC	OS	Tertile	II,III,IV	0.218	0.715	.002	72	view →
KIRC	DFS	Tertile	All	0.149	0.628	.010	54	view →
LUAD	DFS	Tertile	II,III,IV	0.913	0.521	.014	48	view →
BLCA	DFS	Tertile	All	0.208	0.526	.016	36	view →
SKCM	DFS	Tertile	III,IV	0.015	0.648	<.001	18	view →
UCEC	DFS	Tertile	All	0.634	0.842	.019	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
BRCA	OS	Tertile	III,IV	0.624	0.908	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-503P–MESO (OS)

Open the MESO breakdown →